nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Clonus—Cisplatin—esophageal cancer	0.0737	0.0811	CcSEcCtD
Hyoscyamine—Temperature intolerance—Capecitabine—esophageal cancer	0.0381	0.042	CcSEcCtD
Hyoscyamine—Atrial arrhythmia—Capecitabine—esophageal cancer	0.0225	0.0248	CcSEcCtD
Hyoscyamine—Speech impairment NOS—Methotrexate—esophageal cancer	0.0213	0.0235	CcSEcCtD
Hyoscyamine—Scab—Capecitabine—esophageal cancer	0.0197	0.0217	CcSEcCtD
Hyoscyamine—Slurred speech—Cisplatin—esophageal cancer	0.019	0.0209	CcSEcCtD
Hyoscyamine—Arrhythmia supraventricular—Capecitabine—esophageal cancer	0.0161	0.0178	CcSEcCtD
Hyoscyamine—Sinus tachycardia—Capecitabine—esophageal cancer	0.0155	0.0171	CcSEcCtD
Hyoscyamine—Blindness—Cisplatin—esophageal cancer	0.0153	0.0169	CcSEcCtD
Hyoscyamine—Rash macular—Capecitabine—esophageal cancer	0.0153	0.0168	CcSEcCtD
Hyoscyamine—Ileus paralytic—Capecitabine—esophageal cancer	0.0145	0.0159	CcSEcCtD
Hyoscyamine—Balance disorder—Capecitabine—esophageal cancer	0.0114	0.0126	CcSEcCtD
Hyoscyamine—Visual acuity reduced—Capecitabine—esophageal cancer	0.0105	0.0116	CcSEcCtD
Hyoscyamine—Ageusia—Cisplatin—esophageal cancer	0.0105	0.0115	CcSEcCtD
Hyoscyamine—Loss of libido—Methotrexate—esophageal cancer	0.0101	0.0111	CcSEcCtD
Hyoscyamine—Keratitis—Capecitabine—esophageal cancer	0.00965	0.0106	CcSEcCtD
Hyoscyamine—Supraventricular tachycardia—Capecitabine—esophageal cancer	0.00955	0.0105	CcSEcCtD
Hyoscyamine—Haemoglobin decreased—Capecitabine—esophageal cancer	0.00909	0.01	CcSEcCtD
Hyoscyamine—Dysarthria—Cisplatin—esophageal cancer	0.00898	0.00988	CcSEcCtD
Hyoscyamine—Pain—Carboplatin—esophageal cancer	0.00883	0.00972	CcSEcCtD
Hyoscyamine—Laryngitis—Capecitabine—esophageal cancer	0.00868	0.00956	CcSEcCtD
Hyoscyamine—Rash erythematous—Capecitabine—esophageal cancer	0.00817	0.009	CcSEcCtD
Hyoscyamine—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00817	0.009	CcSEcCtD
Hyoscyamine—Body temperature increased—Carboplatin—esophageal cancer	0.00816	0.00899	CcSEcCtD
Hyoscyamine—Skin exfoliation—Cisplatin—esophageal cancer	0.00811	0.00892	CcSEcCtD
Hyoscyamine—Ageusia—Capecitabine—esophageal cancer	0.00773	0.0085	CcSEcCtD
Hyoscyamine—Petechiae—Capecitabine—esophageal cancer	0.00761	0.00837	CcSEcCtD
Hyoscyamine—Extrasystoles—Capecitabine—esophageal cancer	0.00744	0.00819	CcSEcCtD
Hyoscyamine—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00693	0.00763	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00693	0.00763	CcSEcCtD
Hyoscyamine—Nasal congestion—Cisplatin—esophageal cancer	0.00677	0.00745	CcSEcCtD
Hyoscyamine—Paralysis—Methotrexate—esophageal cancer	0.00671	0.00738	CcSEcCtD
Hyoscyamine—Dysarthria—Capecitabine—esophageal cancer	0.00662	0.00728	CcSEcCtD
Hyoscyamine—Cyanosis—Methotrexate—esophageal cancer	0.00658	0.00725	CcSEcCtD
Hyoscyamine—Amnesia—Cisplatin—esophageal cancer	0.00656	0.00722	CcSEcCtD
Hyoscyamine—Blood pressure increased—Capecitabine—esophageal cancer	0.00626	0.00689	CcSEcCtD
Hyoscyamine—Stupor—Methotrexate—esophageal cancer	0.00624	0.00687	CcSEcCtD
Hyoscyamine—Injection site reaction—Capecitabine—esophageal cancer	0.00622	0.00685	CcSEcCtD
Hyoscyamine—Hyponatraemia—Cisplatin—esophageal cancer	0.00619	0.00681	CcSEcCtD
Hyoscyamine—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00604	0.00665	CcSEcCtD
Hyoscyamine—Skin exfoliation—Capecitabine—esophageal cancer	0.00598	0.00658	CcSEcCtD
Hyoscyamine—Irritability—Cisplatin—esophageal cancer	0.00588	0.00648	CcSEcCtD
Hyoscyamine—Dry eye—Capecitabine—esophageal cancer	0.00578	0.00636	CcSEcCtD
Hyoscyamine—Dehydration—Cisplatin—esophageal cancer	0.00573	0.00631	CcSEcCtD
Hyoscyamine—Petechiae—Methotrexate—esophageal cancer	0.00566	0.00623	CcSEcCtD
Hyoscyamine—Hypokalaemia—Cisplatin—esophageal cancer	0.00561	0.00617	CcSEcCtD
Hyoscyamine—Speech disorder—Methotrexate—esophageal cancer	0.00542	0.00596	CcSEcCtD
Hyoscyamine—Swelling—Capecitabine—esophageal cancer	0.00515	0.00567	CcSEcCtD
Hyoscyamine—Eye pain—Capecitabine—esophageal cancer	0.00503	0.00554	CcSEcCtD
Hyoscyamine—Dysarthria—Methotrexate—esophageal cancer	0.00493	0.00542	CcSEcCtD
Hyoscyamine—Amnesia—Capecitabine—esophageal cancer	0.00484	0.00532	CcSEcCtD
Hyoscyamine—Atrial fibrillation—Capecitabine—esophageal cancer	0.00479	0.00528	CcSEcCtD
Hyoscyamine—Thirst—Capecitabine—esophageal cancer	0.00477	0.00525	CcSEcCtD
Hyoscyamine—Respiratory failure—Methotrexate—esophageal cancer	0.00474	0.00522	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00468	0.00515	CcSEcCtD
Hyoscyamine—Myocardial infarction—Cisplatin—esophageal cancer	0.00466	0.00512	CcSEcCtD
Hyoscyamine—Lethargy—Capecitabine—esophageal cancer	0.00464	0.0051	CcSEcCtD
Hyoscyamine—Conjunctivitis—Cisplatin—esophageal cancer	0.00462	0.00508	CcSEcCtD
Hyoscyamine—Hyponatraemia—Capecitabine—esophageal cancer	0.00456	0.00502	CcSEcCtD
Hyoscyamine—Osteoarthritis—Capecitabine—esophageal cancer	0.00454	0.005	CcSEcCtD
Hyoscyamine—Depressed level of consciousness—Methotrexate—esophageal cancer	0.0045	0.00495	CcSEcCtD
Hyoscyamine—Skin exfoliation—Methotrexate—esophageal cancer	0.00445	0.0049	CcSEcCtD
Hyoscyamine—Bradycardia—Cisplatin—esophageal cancer	0.00434	0.00478	CcSEcCtD
Hyoscyamine—Irritability—Capecitabine—esophageal cancer	0.00434	0.00477	CcSEcCtD
Hyoscyamine—Urinary retention—Capecitabine—esophageal cancer	0.00432	0.00476	CcSEcCtD
Hyoscyamine—Cardiac arrest—Capecitabine—esophageal cancer	0.00432	0.00476	CcSEcCtD
Hyoscyamine—Ataxia—Capecitabine—esophageal cancer	0.00427	0.0047	CcSEcCtD
Hyoscyamine—Coma—Methotrexate—esophageal cancer	0.00426	0.00469	CcSEcCtD
Hyoscyamine—Dehydration—Capecitabine—esophageal cancer	0.00422	0.00465	CcSEcCtD
Hyoscyamine—Dry skin—Capecitabine—esophageal cancer	0.00416	0.00458	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Methotrexate—esophageal cancer	0.00415	0.00456	CcSEcCtD
Hyoscyamine—Hypokalaemia—Capecitabine—esophageal cancer	0.00413	0.00455	CcSEcCtD
Hyoscyamine—Flushing—Cisplatin—esophageal cancer	0.00396	0.00436	CcSEcCtD
Hyoscyamine—Abdominal distension—Capecitabine—esophageal cancer	0.00395	0.00435	CcSEcCtD
Hyoscyamine—Dysphagia—Capecitabine—esophageal cancer	0.00393	0.00432	CcSEcCtD
Hyoscyamine—Angina pectoris—Capecitabine—esophageal cancer	0.00382	0.00421	CcSEcCtD
Hyoscyamine—Arrhythmia—Cisplatin—esophageal cancer	0.00381	0.00419	CcSEcCtD
Hyoscyamine—Erythema—Cisplatin—esophageal cancer	0.00371	0.00409	CcSEcCtD
Hyoscyamine—Dysuria—Capecitabine—esophageal cancer	0.00367	0.00404	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Capecitabine—esophageal cancer	0.00354	0.0039	CcSEcCtD
Hyoscyamine—Vision blurred—Cisplatin—esophageal cancer	0.0035	0.00385	CcSEcCtD
Hyoscyamine—Depression—Capecitabine—esophageal cancer	0.00349	0.00384	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00345	0.0038	CcSEcCtD
Hyoscyamine—Lethargy—Methotrexate—esophageal cancer	0.00345	0.0038	CcSEcCtD
Hyoscyamine—Myocardial infarction—Capecitabine—esophageal cancer	0.00343	0.00378	CcSEcCtD
Hyoscyamine—Conjunctivitis—Capecitabine—esophageal cancer	0.0034	0.00375	CcSEcCtD
Hyoscyamine—Osteoarthritis—Methotrexate—esophageal cancer	0.00338	0.00372	CcSEcCtD
Hyoscyamine—Irritability—Methotrexate—esophageal cancer	0.00323	0.00355	CcSEcCtD
Hyoscyamine—Convulsion—Cisplatin—esophageal cancer	0.00322	0.00354	CcSEcCtD
Hyoscyamine—Bradycardia—Capecitabine—esophageal cancer	0.0032	0.00352	CcSEcCtD
Hyoscyamine—Ataxia—Methotrexate—esophageal cancer	0.00318	0.0035	CcSEcCtD
Hyoscyamine—Anxiety—Cisplatin—esophageal cancer	0.00315	0.00347	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00303	0.00333	CcSEcCtD
Hyoscyamine—Oedema—Cisplatin—esophageal cancer	0.00303	0.00333	CcSEcCtD
Hyoscyamine—Tachycardia—Cisplatin—esophageal cancer	0.00296	0.00325	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00293	0.00322	CcSEcCtD
Hyoscyamine—Flushing—Capecitabine—esophageal cancer	0.00292	0.00321	CcSEcCtD
Hyoscyamine—Hypotension—Cisplatin—esophageal cancer	0.00283	0.00312	CcSEcCtD
Hyoscyamine—Arrhythmia—Capecitabine—esophageal cancer	0.00281	0.00309	CcSEcCtD
Hyoscyamine—Mental disorder—Capecitabine—esophageal cancer	0.00275	0.00303	CcSEcCtD
Hyoscyamine—Erythema—Capecitabine—esophageal cancer	0.00274	0.00301	CcSEcCtD
Hyoscyamine—Dysuria—Methotrexate—esophageal cancer	0.00273	0.00301	CcSEcCtD
Hyoscyamine—Dyspnoea—Cisplatin—esophageal cancer	0.0027	0.00297	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Methotrexate—esophageal cancer	0.00269	0.00296	CcSEcCtD
Hyoscyamine—Dysgeusia—Capecitabine—esophageal cancer	0.00268	0.00295	CcSEcCtD
Hyoscyamine—Drowsiness—Methotrexate—esophageal cancer	0.00261	0.00287	CcSEcCtD
Hyoscyamine—Depression—Methotrexate—esophageal cancer	0.0026	0.00286	CcSEcCtD
Hyoscyamine—Pain—Cisplatin—esophageal cancer	0.00259	0.00285	CcSEcCtD
Hyoscyamine—Vision blurred—Capecitabine—esophageal cancer	0.00258	0.00284	CcSEcCtD
Hyoscyamine—Conjunctivitis—Methotrexate—esophageal cancer	0.00253	0.00279	CcSEcCtD
Hyoscyamine—Sweating—Methotrexate—esophageal cancer	0.0025	0.00275	CcSEcCtD
Hyoscyamine—Feeling abnormal—Cisplatin—esophageal cancer	0.0025	0.00275	CcSEcCtD
Hyoscyamine—Vertigo—Capecitabine—esophageal cancer	0.00246	0.00271	CcSEcCtD
Hyoscyamine—Syncope—Capecitabine—esophageal cancer	0.00245	0.0027	CcSEcCtD
Hyoscyamine—Palpitations—Capecitabine—esophageal cancer	0.00242	0.00266	CcSEcCtD
Hyoscyamine—Loss of consciousness—Capecitabine—esophageal cancer	0.0024	0.00265	CcSEcCtD
Hyoscyamine—Body temperature increased—Cisplatin—esophageal cancer	0.00239	0.00264	CcSEcCtD
Hyoscyamine—Chest pain—Capecitabine—esophageal cancer	0.00233	0.00256	CcSEcCtD
Hyoscyamine—Anxiety—Capecitabine—esophageal cancer	0.00232	0.00256	CcSEcCtD
Hyoscyamine—Dry mouth—Capecitabine—esophageal cancer	0.00228	0.00251	CcSEcCtD
Hyoscyamine—Confusional state—Capecitabine—esophageal cancer	0.00225	0.00248	CcSEcCtD
Hyoscyamine—Oedema—Capecitabine—esophageal cancer	0.00223	0.00246	CcSEcCtD
Hyoscyamine—Hypersensitivity—Cisplatin—esophageal cancer	0.00223	0.00246	CcSEcCtD
Hyoscyamine—Shock—Capecitabine—esophageal cancer	0.0022	0.00242	CcSEcCtD
Hyoscyamine—Tachycardia—Capecitabine—esophageal cancer	0.00218	0.0024	CcSEcCtD
Hyoscyamine—Asthenia—Cisplatin—esophageal cancer	0.00217	0.00239	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00216	0.00238	CcSEcCtD
Hyoscyamine—Hypotension—Capecitabine—esophageal cancer	0.00209	0.0023	CcSEcCtD
Hyoscyamine—Diarrhoea—Cisplatin—esophageal cancer	0.00207	0.00228	CcSEcCtD
Hyoscyamine—Mental disorder—Methotrexate—esophageal cancer	0.00205	0.00226	CcSEcCtD
Hyoscyamine—Erythema—Methotrexate—esophageal cancer	0.00204	0.00224	CcSEcCtD
Hyoscyamine—Insomnia—Capecitabine—esophageal cancer	0.00202	0.00222	CcSEcCtD
Hyoscyamine—Dysgeusia—Methotrexate—esophageal cancer	0.00199	0.0022	CcSEcCtD
Hyoscyamine—Dyspnoea—Capecitabine—esophageal cancer	0.00199	0.00219	CcSEcCtD
Hyoscyamine—Dyspepsia—Capecitabine—esophageal cancer	0.00197	0.00216	CcSEcCtD
Hyoscyamine—Vomiting—Cisplatin—esophageal cancer	0.00193	0.00212	CcSEcCtD
Hyoscyamine—Fatigue—Capecitabine—esophageal cancer	0.00193	0.00212	CcSEcCtD
Hyoscyamine—Vision blurred—Methotrexate—esophageal cancer	0.00192	0.00211	CcSEcCtD
Hyoscyamine—Rash—Cisplatin—esophageal cancer	0.00191	0.0021	CcSEcCtD
Hyoscyamine—Pain—Capecitabine—esophageal cancer	0.00191	0.0021	CcSEcCtD
Hyoscyamine—Constipation—Capecitabine—esophageal cancer	0.00191	0.0021	CcSEcCtD
Hyoscyamine—Dermatitis—Cisplatin—esophageal cancer	0.00191	0.0021	CcSEcCtD
Hyoscyamine—Feeling abnormal—Capecitabine—esophageal cancer	0.00184	0.00203	CcSEcCtD
Hyoscyamine—Vertigo—Methotrexate—esophageal cancer	0.00183	0.00201	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00183	0.00201	CcSEcCtD
Hyoscyamine—Nausea—Cisplatin—esophageal cancer	0.0018	0.00198	CcSEcCtD
Hyoscyamine—Urticaria—Capecitabine—esophageal cancer	0.00177	0.00195	CcSEcCtD
Hyoscyamine—Abdominal pain—Capecitabine—esophageal cancer	0.00177	0.00194	CcSEcCtD
Hyoscyamine—Body temperature increased—Capecitabine—esophageal cancer	0.00177	0.00194	CcSEcCtD
Hyoscyamine—Convulsion—Methotrexate—esophageal cancer	0.00176	0.00194	CcSEcCtD
Hyoscyamine—Chest pain—Methotrexate—esophageal cancer	0.00173	0.00191	CcSEcCtD
Hyoscyamine—Confusional state—Methotrexate—esophageal cancer	0.00168	0.00184	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Methotrexate—esophageal cancer	0.00166	0.00183	CcSEcCtD
Hyoscyamine—Hypersensitivity—Capecitabine—esophageal cancer	0.00165	0.00181	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Methotrexate—esophageal cancer	0.00161	0.00177	CcSEcCtD
Hyoscyamine—Asthenia—Capecitabine—esophageal cancer	0.0016	0.00176	CcSEcCtD
Hyoscyamine—Pruritus—Capecitabine—esophageal cancer	0.00158	0.00174	CcSEcCtD
Hyoscyamine—Hypotension—Methotrexate—esophageal cancer	0.00155	0.00171	CcSEcCtD
Hyoscyamine—Diarrhoea—Capecitabine—esophageal cancer	0.00153	0.00168	CcSEcCtD
Hyoscyamine—Insomnia—Methotrexate—esophageal cancer	0.0015	0.00165	CcSEcCtD
Hyoscyamine—Dyspnoea—Methotrexate—esophageal cancer	0.00148	0.00163	CcSEcCtD
Hyoscyamine—Somnolence—Methotrexate—esophageal cancer	0.00148	0.00163	CcSEcCtD
Hyoscyamine—Dizziness—Capecitabine—esophageal cancer	0.00148	0.00163	CcSEcCtD
Hyoscyamine—Dyspepsia—Methotrexate—esophageal cancer	0.00146	0.00161	CcSEcCtD
Hyoscyamine—Fatigue—Methotrexate—esophageal cancer	0.00143	0.00158	CcSEcCtD
Hyoscyamine—Pain—Methotrexate—esophageal cancer	0.00142	0.00156	CcSEcCtD
Hyoscyamine—Vomiting—Capecitabine—esophageal cancer	0.00142	0.00156	CcSEcCtD
Hyoscyamine—Rash—Capecitabine—esophageal cancer	0.00141	0.00155	CcSEcCtD
Hyoscyamine—Dermatitis—Capecitabine—esophageal cancer	0.00141	0.00155	CcSEcCtD
Hyoscyamine—Headache—Capecitabine—esophageal cancer	0.0014	0.00154	CcSEcCtD
Hyoscyamine—Feeling abnormal—Methotrexate—esophageal cancer	0.00137	0.00151	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00136	0.0015	CcSEcCtD
Hyoscyamine—Nausea—Capecitabine—esophageal cancer	0.00133	0.00146	CcSEcCtD
Hyoscyamine—Urticaria—Methotrexate—esophageal cancer	0.00132	0.00145	CcSEcCtD
Hyoscyamine—Abdominal pain—Methotrexate—esophageal cancer	0.00131	0.00145	CcSEcCtD
Hyoscyamine—Body temperature increased—Methotrexate—esophageal cancer	0.00131	0.00145	CcSEcCtD
Hyoscyamine—Hypersensitivity—Methotrexate—esophageal cancer	0.00122	0.00135	CcSEcCtD
Hyoscyamine—Asthenia—Methotrexate—esophageal cancer	0.00119	0.00131	CcSEcCtD
Hyoscyamine—Pruritus—Methotrexate—esophageal cancer	0.00118	0.00129	CcSEcCtD
Hyoscyamine—Diarrhoea—Methotrexate—esophageal cancer	0.00114	0.00125	CcSEcCtD
Hyoscyamine—Dizziness—Methotrexate—esophageal cancer	0.0011	0.00121	CcSEcCtD
Hyoscyamine—Vomiting—Methotrexate—esophageal cancer	0.00106	0.00116	CcSEcCtD
Hyoscyamine—Rash—Methotrexate—esophageal cancer	0.00105	0.00115	CcSEcCtD
Hyoscyamine—Dermatitis—Methotrexate—esophageal cancer	0.00105	0.00115	CcSEcCtD
Hyoscyamine—Headache—Methotrexate—esophageal cancer	0.00104	0.00115	CcSEcCtD
Hyoscyamine—Nausea—Methotrexate—esophageal cancer	0.000987	0.00109	CcSEcCtD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKAP13—esophageal cancer	0.000162	0.00177	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKAP13—esophageal cancer	0.000162	0.00177	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CA1—esophageal cancer	0.000161	0.00176	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—SLC10A2—esophageal cancer	0.000161	0.00176	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKAP13—esophageal cancer	0.00016	0.00175	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CSNK1A1—esophageal cancer	0.000157	0.00172	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—ANXA1—esophageal cancer	0.000156	0.0017	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KMT2D—esophageal cancer	0.000152	0.00166	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—SST—esophageal cancer	0.000152	0.00166	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KMT2D—esophageal cancer	0.000151	0.00165	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000151	0.00165	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KMT2D—esophageal cancer	0.00015	0.00164	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PDE4D—esophageal cancer	0.000149	0.00162	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PDE4D—esophageal cancer	0.000148	0.00162	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—GHRL—esophageal cancer	0.000148	0.00161	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKAP13—esophageal cancer	0.000147	0.00161	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CA2—esophageal cancer	0.000147	0.00161	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PFN1—esophageal cancer	0.000147	0.00161	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKAP13—esophageal cancer	0.000147	0.00161	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PDE4D—esophageal cancer	0.000147	0.0016	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKAP13—esophageal cancer	0.000146	0.00159	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—GNG7—esophageal cancer	0.000141	0.00154	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—GNG7—esophageal cancer	0.000141	0.00154	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—GNG7—esophageal cancer	0.000139	0.00152	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PLCE1—esophageal cancer	0.000137	0.0015	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ADH7—esophageal cancer	0.000137	0.0015	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000135	0.00148	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PDE4D—esophageal cancer	0.000135	0.00147	CbGpPWpGaD
Hyoscyamine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—esophageal cancer	0.000135	0.00147	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ADCYAP1—esophageal cancer	0.000135	0.00147	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PDE4D—esophageal cancer	0.000134	0.00147	CbGpPWpGaD
Hyoscyamine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—esophageal cancer	0.000134	0.00147	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ADCYAP1—esophageal cancer	0.000133	0.00146	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PDE4D—esophageal cancer	0.000133	0.00145	CbGpPWpGaD
Hyoscyamine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—esophageal cancer	0.000133	0.00145	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ELMO1—esophageal cancer	0.000132	0.00144	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKAP13—esophageal cancer	0.000129	0.00141	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—GNG7—esophageal cancer	0.000128	0.0014	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—GNG7—esophageal cancer	0.000128	0.0014	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—GNG7—esophageal cancer	0.000127	0.00138	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—EP300—esophageal cancer	0.000125	0.00136	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000124	0.00136	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCL2—esophageal cancer	0.000124	0.00136	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—WWOX—esophageal cancer	0.000124	0.00135	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—WWOX—esophageal cancer	0.000123	0.00135	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCL2—esophageal cancer	0.000123	0.00134	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—WWOX—esophageal cancer	0.000122	0.00133	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ADH1B—esophageal cancer	0.00012	0.00131	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000119	0.0013	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PDE4D—esophageal cancer	0.000118	0.00129	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FKBP1A—esophageal cancer	0.000118	0.00128	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FKBP1A—esophageal cancer	0.000117	0.00128	CbGpPWpGaD
Hyoscyamine—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000117	0.00128	CbGpPWpGaD
Hyoscyamine—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000117	0.00127	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FKBP1A—esophageal cancer	0.000116	0.00127	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—ANXA1—esophageal cancer	0.000116	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000116	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—ANXA1—esophageal cancer	0.000115	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—WIF1—esophageal cancer	0.000115	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—TYMP—esophageal cancer	0.000115	0.00125	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—WIF1—esophageal cancer	0.000115	0.00125	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—ANXA1—esophageal cancer	0.000114	0.00125	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—WIF1—esophageal cancer	0.000113	0.00124	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL2—esophageal cancer	0.000113	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL2—esophageal cancer	0.000113	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—SST—esophageal cancer	0.000113	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—GNG7—esophageal cancer	0.000112	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—SST—esophageal cancer	0.000112	0.00123	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CYP26A1—esophageal cancer	0.000112	0.00122	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL2—esophageal cancer	0.000112	0.00122	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—SST—esophageal cancer	0.000111	0.00121	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—GHRL—esophageal cancer	0.00011	0.0012	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—GHRL—esophageal cancer	0.000109	0.00119	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALOX15—esophageal cancer	0.000109	0.00119	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	0.000108	0.00118	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000106	0.00116	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CSNK1A1—esophageal cancer	0.000106	0.00116	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—XIAP—esophageal cancer	0.000105	0.00115	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—ANXA1—esophageal cancer	0.000105	0.00115	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—ANXA1—esophageal cancer	0.000105	0.00114	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000105	0.00114	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—TPI1—esophageal cancer	0.000104	0.00113	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GSTO1—esophageal cancer	0.000104	0.00113	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	0.000104	0.00113	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—SST—esophageal cancer	0.000102	0.00112	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—SST—esophageal cancer	0.000102	0.00111	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—SST—esophageal cancer	0.000101	0.0011	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000101	0.0011	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.0001	0.0011	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—GHRL—esophageal cancer	9.96e-05	0.00109	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CTNNA1—esophageal cancer	9.96e-05	0.00109	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALDOB—esophageal cancer	9.96e-05	0.00109	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—GHRL—esophageal cancer	9.93e-05	0.00108	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PFN1—esophageal cancer	9.92e-05	0.00108	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL2—esophageal cancer	9.9e-05	0.00108	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PFN1—esophageal cancer	9.89e-05	0.00108	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	9.83e-05	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PFN1—esophageal cancer	9.79e-05	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM1—G alpha (q) signalling events—PIK3CA—esophageal cancer	9.76e-05	0.00107	CbGpPWpGaD
Hyoscyamine—CHRM3—G alpha (q) signalling events—PIK3CA—esophageal cancer	9.73e-05	0.00106	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GAPDH—esophageal cancer	9.58e-05	0.00105	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CRABP1—esophageal cancer	9.5e-05	0.00104	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PSME1—esophageal cancer	9.25e-05	0.00101	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PSME2—esophageal cancer	9.25e-05	0.00101	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ANXA1—esophageal cancer	9.2e-05	0.00101	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GNG7—esophageal cancer	9.03e-05	0.000987	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SST—esophageal cancer	8.95e-05	0.000978	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ELMO1—esophageal cancer	8.91e-05	0.000974	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—TP53—esophageal cancer	8.91e-05	0.000974	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ELMO1—esophageal cancer	8.88e-05	0.000971	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	8.8e-05	0.000961	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	8.73e-05	0.000954	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NOTCH3—esophageal cancer	8.73e-05	0.000953	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—GHRL—esophageal cancer	8.73e-05	0.000953	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKAP13—esophageal cancer	8.71e-05	0.000952	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	8.7e-05	0.000951	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKAP13—esophageal cancer	8.68e-05	0.000949	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	8.6e-05	0.000939	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—FBXW7—esophageal cancer	8.58e-05	0.000938	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALDH2—esophageal cancer	8.46e-05	0.000925	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GSTT1—esophageal cancer	8.05e-05	0.00088	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	8.04e-05	0.000878	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HIST1H2BM—esophageal cancer	8.01e-05	0.000876	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	7.97e-05	0.00087	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CYP2A6—esophageal cancer	7.96e-05	0.00087	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PDE4D—esophageal cancer	7.94e-05	0.000868	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	7.94e-05	0.000867	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	7.86e-05	0.000859	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NOTCH2—esophageal cancer	7.83e-05	0.000855	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GNG7—esophageal cancer	7.58e-05	0.000828	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GNG7—esophageal cancer	7.55e-05	0.000825	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ENO1—esophageal cancer	7.54e-05	0.000824	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTGS1—esophageal cancer	7.54e-05	0.000824	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GNG7—esophageal cancer	7.48e-05	0.000817	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PSME1—esophageal cancer	7.43e-05	0.000812	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PSME2—esophageal cancer	7.43e-05	0.000812	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—XIAP—esophageal cancer	7.1e-05	0.000776	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—XIAP—esophageal cancer	7.08e-05	0.000773	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—XIAP—esophageal cancer	7.01e-05	0.000766	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TGFBR2—esophageal cancer	6.94e-05	0.000759	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	6.71e-05	0.000734	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CTNNA1—esophageal cancer	6.69e-05	0.000731	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	6.68e-05	0.000729	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL2—esophageal cancer	6.65e-05	0.000727	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	6.63e-05	0.000724	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	6.59e-05	0.00072	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SMAD4—esophageal cancer	6.57e-05	0.000718	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CYP1B1—esophageal cancer	6.42e-05	0.000701	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PSME2—esophageal cancer	6.24e-05	0.000681	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PSME1—esophageal cancer	6.24e-05	0.000681	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PSME1—esophageal cancer	6.22e-05	0.000679	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PSME2—esophageal cancer	6.22e-05	0.000679	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	6.21e-05	0.000678	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ANXA1—esophageal cancer	6.19e-05	0.000676	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PSME1—esophageal cancer	6.16e-05	0.000673	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PSME2—esophageal cancer	6.16e-05	0.000673	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	6.13e-05	0.000669	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SST—esophageal cancer	6.04e-05	0.00066	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CYP19A1—esophageal cancer	6.03e-05	0.000659	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SST—esophageal cancer	6.02e-05	0.000658	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SST—esophageal cancer	5.96e-05	0.000651	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GHRL—esophageal cancer	5.88e-05	0.000643	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	5.88e-05	0.000643	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOTCH3—esophageal cancer	5.86e-05	0.000641	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GHRL—esophageal cancer	5.86e-05	0.000641	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GHRL—esophageal cancer	5.81e-05	0.000635	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	5.81e-05	0.000635	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	5.79e-05	0.000632	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	5.77e-05	0.00063	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	5.71e-05	0.000624	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—HMOX1—esophageal cancer	5.5e-05	0.000601	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HIF1A—esophageal cancer	5.38e-05	0.000588	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ABCB1—esophageal cancer	5.28e-05	0.000577	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	5.28e-05	0.000577	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	5.26e-05	0.000575	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	5.21e-05	0.000569	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—KDR—esophageal cancer	5.14e-05	0.000562	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NOTCH1—esophageal cancer	4.84e-05	0.000529	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	4.68e-05	0.000511	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	4.67e-05	0.00051	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	4.62e-05	0.000505	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	4.43e-05	0.000484	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	4.42e-05	0.000483	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CREBBP—esophageal cancer	4.39e-05	0.00048	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	4.37e-05	0.000478	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—EGFR—esophageal cancer	4.32e-05	0.000472	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—PIK3CA—esophageal cancer	4.13e-05	0.000451	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NOS3—esophageal cancer	3.93e-05	0.00043	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—PIK3CA—esophageal cancer	3.75e-05	0.000409	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ERBB2—esophageal cancer	3.68e-05	0.000402	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	3.63e-05	0.000396	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	3.61e-05	0.000395	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	3.58e-05	0.000391	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CREBBP—esophageal cancer	3.53e-05	0.000386	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KDR—esophageal cancer	3.47e-05	0.000379	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KDR—esophageal cancer	3.46e-05	0.000378	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KDR—esophageal cancer	3.42e-05	0.000374	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	3.27e-05	0.000357	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	3.26e-05	0.000356	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCND1—esophageal cancer	3.25e-05	0.000355	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	3.22e-05	0.000352	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—NOS3—esophageal cancer	3.16e-05	0.000345	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CDKN1A—esophageal cancer	3.14e-05	0.000344	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EP300—esophageal cancer	2.99e-05	0.000327	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	2.96e-05	0.000324	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	2.95e-05	0.000323	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	2.92e-05	0.000319	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	2.91e-05	0.000318	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	2.9e-05	0.000317	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTGS2—esophageal cancer	2.89e-05	0.000316	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	2.87e-05	0.000314	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	2.78e-05	0.000304	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	2.77e-05	0.000303	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	2.75e-05	0.0003	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOS3—esophageal cancer	2.65e-05	0.00029	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOS3—esophageal cancer	2.64e-05	0.000289	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOS3—esophageal cancer	2.62e-05	0.000286	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MYC—esophageal cancer	2.61e-05	0.000285	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EGFR—esophageal cancer	2.55e-05	0.000279	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	2.53e-05	0.000276	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	2.52e-05	0.000275	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	2.49e-05	0.000272	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	2.48e-05	0.000271	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	2.47e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	2.45e-05	0.000268	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—EP300—esophageal cancer	2.4e-05	0.000263	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CA—esophageal cancer	2.21e-05	0.000242	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCND1—esophageal cancer	2.19e-05	0.000239	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCND1—esophageal cancer	2.18e-05	0.000239	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCND1—esophageal cancer	2.16e-05	0.000236	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TP53—esophageal cancer	2.14e-05	0.000234	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	2.12e-05	0.000232	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	2.11e-05	0.000231	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	2.09e-05	0.000229	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EP300—esophageal cancer	2.02e-05	0.00022	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EP300—esophageal cancer	2.01e-05	0.00022	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EP300—esophageal cancer	1.99e-05	0.000218	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CA—esophageal cancer	1.78e-05	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MYC—esophageal cancer	1.76e-05	0.000192	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MYC—esophageal cancer	1.75e-05	0.000191	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MYC—esophageal cancer	1.74e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EGFR—esophageal cancer	1.72e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EGFR—esophageal cancer	1.71e-05	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EGFR—esophageal cancer	1.7e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	1.49e-05	0.000163	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	1.49e-05	0.000163	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	1.47e-05	0.000161	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TP53—esophageal cancer	1.44e-05	0.000158	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TP53—esophageal cancer	1.44e-05	0.000157	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TP53—esophageal cancer	1.42e-05	0.000156	CbGpPWpGaD
